$Context Therapeutics(CNTX.US)$Important Regulatory Milestone Supports Next Phase of CTIM-76 Development PHILADELPHIA, April 01, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. ("Context" or the "Company") (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced that on March 28, 2024, the Company submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration to begin a first-in-human clinical study of CTIM-76. ...
Context Therapeutics股票讨论区
Update
PHILADELPHIA, April 01, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. ("Context" or the "Company") (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced that on March 28, 2024, the Company submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration to begin a first-in-human clinical study of CTIM-76. ...
what a great day trading - winning made simple
$Context Therapeutics(CNTX.US)$
$cbdMD(YCBD.US)$
$苏轩堂(SXTC.US)$
$中国绿色农业(CGA.US)$
multiple winners 🏆💪🏻
Apextradez 🔗 up with me 🤩 supporters get free access to mega elite alerts 🫵🏻 can win if you want to get serious in 2024 and winning is your goal
$Dcth massive fda approval
Move in on panic
will it continue to rise?
@Matthew D
have u sell?
Will you 🚀🚀🚀🚀🚀🚀🚀🚀
暂无评论